News
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen ... though Jorgensen had predicted a return to growth in its biggest market — the United States — in the second ...
Novo Nordisk ... of Medicine showed that people lost more weight using Wegovy competitor Zepbound, made by pharmaceutical company Eli Lilly. Eli Lilly funded the study. Novo Nordisk's share ...
Novo Nordisk (NVO) announced a new $2.2 billion ... The deal is the latest in a series focused on the pill market for obesity, deemed the next frontier in the race for the next generation of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results